No Detail Found!

Comparative analysis of magnesium sulfate and atosiban in fetal neuroprotection during high-risk pregnancies

Author(s)
Lijuan Pan Department of Obstetrics, Affiliated Hospital of Jiangsu University,438 Jiefang Road, Zhenjiang, Jiangsu Province,China
Ning Zhang Department of Obstetrics, Affiliated Hospital of Jiangsu University,438 Jiefang Road, Zhenjiang, Jiangsu Province,China
Abstract
Preterm births could increase the risk of neonatal conditions like cerebral palsy and neurodevelopmental delays. This trial aimed to evaluate the efficacy of magnesium sulfate and atosiban in providing neuroprotection to preterm infants. A clinical trial was conducted between 2020 and 2024, involving 102 high-risk pregnant women at multiple tertiary clinics in China. We studied the neonatal neurodevelopmental delay at 6 months and 12 months whilst also focusing on factors such as maternal side effects, gestational age, mode of delivery, and Neonatal Intensive Care Unit (NICU) admission rates. Unlike magnesium sulfate, Atosiban could reduce the fetus' breathing problems that can, in turn, lead to baby brain protection. It also has fewer maternal side effects, such as nausea and hypertension (p = 0.03). Magnesium sulfate had comparably higher risks of maternal and fetal complications, 49.02% and 68.63% respectively. This study's results suggest that while atosiban is not a commonly used intervention, it is a promising agent for fetal neuroprotection. It is also observed that considering maternal safety, it has fewer side effects. Future larger population studies should be carried out to corroborate the results for higher efficient and safer intervention for fetal neuroprotection
Publication Details
Page(s) 1685-1693
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 5, Year: 2025

Request the full text from PASTIC

Keywords
High-risk pregnancies, Magnesium Sulfate, Atosiban, fetal neuroprotection
References
Al-Riyami N,Al-Badri H,Jaju S,Pillai S S .2021 .Shortterm outcomes of atosiban in the treatment of preterm labour at the Sultan Qaboos University Hospital. , 21(2) : e260-265.
Chollat C,Sentilhes L,Marret S L .2018 .Fetal neuroprotection by magnesium sulfate: From translational research to clinical application. Front Neurol, 9 : 247.
Hoffman MK,Obstet MK .2021 .Prediction and prevention of spontaneous preterm birth: ACOG practice bulletin, number 234. , 138(6) : 945-946.
Jafarabady K,Shafiee A,Eshraghi N,Salehi SA,Mohammadi I,Rajai S,Zareian Z,Movahed F,Bakhtiyari M .2024 .Magnesium sulfate for fetal neuroprotection in preterm pregnancy: a meta-analysis of randomized controlled trials. BMC Pregnancy Childbirth, 24(1) : 519.
Lakshmanan A,Agni M,Lieu T,Fleegler E,Kipke M,Friedlich PS,McCormick MC,Belfort MB MC .2017 .The impact of preterm birth <37 weeks on parents and families: a cross-sectional study in the 2 years after discharge from the neonatal intensive care unit. Health Qual. Life Outcomes, 15(1) : 38.
Liu H,Wang X,Clin X .2024 .Use of tocolytic agents in preterm labor: A cross-sectional analysis from a chinese real-world study from 2016 to 2021. , : 1-11.
Morniroli D,Tiraferri V,Maiocco G,De Rose DU,Cresi F,Coscia A,Mosca F,Giannì ML .2023 .Beyond survival: The lasting effects of premature birth. Front Pediatr, 11 : 1213243.
Nijman TAJ,Goedhart MM,Naaktgeboren CN,de Haan TR,Vijlbrief DC,Mol BW,Benders MJN,Franx A,Oudijk MA .2018 .Effect of nifedipine and atosiban on perinatal brain injury: Secondary analysis of the APOSTEL-III trial. , 51(6) : 806-812.
Parikh LI,Reddy UM,Männistö T,Mendola P,Sjaarda L,Hinkle S,Chen Z,Lu Z,Laughon Shaheen RS,Ismail RA,Salama EY,Korini SM,Elsaeidy AS .2024 .Efficacy and safety of 12-hour versus 24-hour magnesium sulfate in management of patients with preeclampsia and eclampsia: A systematic review and meta-analysis. BMC Womens Health, 24(1) : 421.
Shepherd ES,Goldsmith S,Doyle LW,Middleton P,Marret S,Rouse DJ,Pryde P,Wolf HT,Crowther CA .2024 .Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst. Rev., 5(5) : CD004661.
Song Q,Chen J,Zhou Y,Li Z,Li H,Liu J .2022 .Preterm delivery rate in China: A systematic review and meta-analysis. BMC Pregnancy Childbirth, 22(1) : 383.
Tsao PC. .2023 .Pathogenesis and prevention of intraventricular hemorrhage in preterm infants. J. Korean Neurosurg. Soc., 66(3) : 228-238.
Wadhwa PD,Entringer S,Buss C,Lu MC C .2011 .The contribution of maternal stress to preterm birth: issues and considerations. Clin. Perinatol, 38(3) : 351-384.
World Health Organization (WHO). .2023 .Preterm birth. , : .
Younger JD,Reitman E,Gallos G .2017 .Tocolysis: Present and future treatment options. Semin Perinatol, 41(8) : 493-504.
Yu Y,Yang Z,Wu L,Zhu Y,Guo F Y .2020 .Effectiveness and safety of atosiban versus conventional treatment in the management of preterm labor. Taiwan J. Obstet. Gynecol., 59(5) : 682-685.
0

Citations

0

Downloads

175

Views